Cipmolnu 200 Capsule 40s MOLNUPIRAVIR

Introduction to Cipmolnu 200 Capsule 40s

Cipmolnu 200 Capsule 40s is an oral medication primarily used to treat mild to moderate COVID-19 in adults who are at risk of severe illness. Cipmolnu 200 Capsule 40s helps reduce the severity of symptoms and lowers the risk of hospitalization.

Composition of Cipmolnu 200 Capsule 40s

Cipmolnu 200 Capsule 40s contains Molnupiravir as its active ingredient. Molnupiravir works by interfering with the virus's ability to replicate, introducing errors into the virus's genetic material, and preventing it from multiplying effectively.

Uses of Cipmolnu 200 Capsule 40s

• Treatment of mild to moderate COVID-19 in adults at risk of severe illness
• Reduction of COVID-19 symptoms severity
• Lowering the risk of COVID-19-related hospitalization

Side effects of Cipmolnu 200 Capsule 40s

• Mild diarrhea
• Nausea
• Dizziness

Precautions of Cipmolnu 200 Capsule 40s

Molnupiravir is not recommended during pregnancy due to potential risks to the unborn baby. It is also not advised for individuals under 18 years old. Always inform your doctor of any allergies or medical conditions before starting Cipmolnu 200 Capsule 40s.

How to Take Cipmolnu 200 Capsule 40s

The usual dose of Cipmolnu 200 Capsule 40s for adults is 800 mg taken twice daily. It is taken orally, usually for five days. Always follow your doctor's specific dosing instructions for the correct usage.

Conclusion of Cipmolnu 200 Capsule 40s

Cipmolnu 200 Capsule 40s, containing Molnupiravir, is part of the therapeutic class of antiviral medications. It is primarily used to treat mild to moderate COVID-19 in adults at risk of severe illness. Always consult your healthcare provider for personalized advice and follow their instructions carefully when using Cipmolnu 200 Capsule 40s.